Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07004400Not ApplicableNot Yet Recruiting

A Blinded Randomized Clinical Study of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of GERD

Role: lead

NCT07004439Not ApplicableNot Yet Recruiting

A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice

Role: lead

NCT05870163Recruiting

Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment

Role: lead

NCT02759094Not ApplicableUnknown

Evaluation of Safety and Effectiveness of the RefluxStop Device in the Management of GERD

Role: lead

All 4 trials loaded